QA: Tenax Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2021_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 6,795,506
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,972
3 remainder_Assets 67,213
4 LiabilitiesCurrent 2,118,963
5 LiabilitiesNoncurrent 124,166
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,274,336
9 ResearchAndDevelopmentExpense 4,264,955
10 remainder_Expenses 945
11 remainder_Revenues 0
12 remainder_NetIncome 41,533
13 remainder_ComprehensiveNetIncome 18,740,503
  yvar yval
0 Assets 6,868,691
1 Liabilities 2,243,129
2 Expenses 9,540,236
3 Revenues 0
4 StockholdersEquity 4,625,562
5 NetIncome -9,498,703
6 ComprehensiveNetIncome -128,452
7 BaseVar 18,717,046
8 EconomicCapitalRatiobeforeLimitedLiability 2.19
9 EconomicCapitalRatio 3.15

Edgar->Model Mapping

Feature Distribution

Change over Time